Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient

American Journal of Health-System Pharmacy

Volumn 60, Issue 22, 2003, Pages 2352-2356

  Sims McCallum, Rosalyn P ^a  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; ANTIINFECTIVE AGENT; CASPOFUNGIN; CEFEPIME; COTRIMOXAZOLE; TSUKUBAENOLIDE; VANCOMYCIN; VORICONAZOLE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CYCLOPEPTIDE; PEPTIDE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ADOLESCENT; ANTIFUNGAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; ASPERGILLOSIS; BLOOD SAMPLING; BODY SURFACE; CASE REPORT; CLINICAL FEATURE; DRUG ACTIVITY; FEMALE; HUMAN; NEUTROPENIA; PRIORITY JOURNAL; TREATMENT OUTCOME; ACUTE GRANULOCYTIC LEUKEMIA; CHILD; DRUG COMBINATION;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; CHILD; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; NEUTROPENIA; PEPTIDES; PEPTIDES, CYCLIC; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLGLYCEROLS; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 1542644762     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.22.2352     Document Type: Article

References (19)

1. Perea S, Patterson TF. Invasive Aspergillus infections in hematologic malignancy patients. Semin Respir Infect. 2002; 17(2):99-105.
2. Koss T, Bagheri B, Zeana C et al. Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent. J Am Acad Dermatol. 2002; 46:945-7.
3. Elstad MR. Aspergillosis and lung defenses. Semin Respir Infect. 1991; 6(1):27-36.
4. Reichenberger F, Habicht JM, Gratwohl A et al. Diagnosis and treatment of invasive pulmonary aspergillosis in neutropenic patients. Eur Respir J. 2002; 19:743-55.
5. Martino R, Subira M. Invasive fungal infections in hematology: new trends. Ann Hematol. 2002; 81:233-43.
6. Miller WT. Aspergillosis: a disease with many faces. Semin Roentgenol. 1996; 31 (1):52-6.
7. Abelcet (amphotericin B lipid complex) package insert. San Diego, CA: Elan Pharmaceuticals; 2002 Jun.
8. Vfend (voriconazole) package insert. New York: Pfizer Roerig; 2002 May.
9. Herbrecht R, Denning DW, Patterson TF et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002; 347:408-15.
10. Walsh TJ, Papas P, Winston DJ et al. Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever. N Engl J Med. 2002; 346:225-34.
11. Walsh TJ, Lutsar I, Driscoll T et al. Voriconazole in the treatment of aspergillosis, scedosporosis and other invasive fungal infections in children. Pediatr Infect Dis J. 2002; 21:240-8.
12. Sporanox (itraconazole) injection package insert. North Chicago, IL: Abbott Laboratories; 2001 Apr.
13. Sporanox (itraconazole) capsules package insert. Beerse, Belgium: Janssen Pharmaceutica; 2002 Feb.
14. Itraconazole. In: Taketomo CK, Hodding JH, Kraus DM, eds. Pediatric dosage handbook. 9th ed. Hudson, OH: Lexicomp; 2002-03:613-5.
15. Bowman JC, Hicks PS, Kurtz MB et al. The antifungal echinocandin caspofungin acetate kills growing cells of Aspergillus fumigatus in vitro. Antimicrob Agents Chemother. 2002; 46:3001-12.
16. Pacetti SA, Gelone SP. Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother. 2003; 37:90-8.
17. Cancidas (caspofungin acetate) package insert. West Point, PA: Merck; 2001 Jan.
18. Sable CA, Nguyen B-YT, Chodakewitz JA et al. Safety and tolerability of caspofungin acetate in the treatment of fungal infections. Transpl Infect Dis. 2002; 4:25-30.
19. Kirkpatrick WR, Perea S, Coco B et al. Efficacy of caspofungin alone and in combination with voriconazole in a guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother. 2002; 46:2564-8.